Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression
Pancreatic ductal adenocarcinoma (PDAC) is a highly fatal metastatic disease associated with robust activation of the coagulation and fibrinolytic systems. However, the potential contribution of the primary fibrinolytic protease plasminogen to PDAC disease progression has remained largely undefined....
Main Authors: | Nayela N. Chowdhury, Yi Yang, Ananya Dutta, Michelle Luo, Zimu Wei, Sara R. Abrahams, Alexey S. Revenko, Fenil Shah, Lindsey A. Miles, Robert J. Parmer, Bas deLaat, Alisa S. Wolberg, James P. Luyendyk, Melissa L. Fishel, Matthew J. Flick |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13552 |
Similar Items
-
Plasminogen Receptors and Fibrinolysis
by: Lindsey A. Miles, et al.
Published: (2021-02-01) -
Characterization of plasmin, plasminogen and plasminogen activator in goat milk
by: F. Polidori, et al.
Published: (2011-03-01) -
The Urokinase Plasminogen Activation System in Pancreatic Cancer: Prospective Diagnostic and Therapeutic Targets
by: Ashna A. Kumar, et al.
Published: (2022-01-01) -
Plasminogen interaction with Trypanosoma cruzi
by: Laura Almeida, et al.
Published: (2004-02-01) -
Study of the sites of plasminogen molecule which are responsible for inhibitory effect of Lys-plasminogen on platelet aggregation
by: Y. M. Roka-Moya, et al.
Published: (2014-10-01)